Cytokeratin 5 - Format: 500 µl

QR027, Rb, 0.5 ml Conc.

Technische Daten
Status:In Vitro Diagnostic Use (IVD)
Ig Unterklasse:IgG
Immunogen:Synthetic peptide of human CK5
Vorbehandlung:ProTaqs® Antigen Enhancer I (Cat. No. 401602092) or ProTaqs® Antigen Enhancer IV (Cat. No. 401602392)
Zelluläre Lokalisation:Cytoplasmic
Kontrolle:Skin, mesothelioma
Change(s) made:Complete revision
Synonyme:Cytokeratin 5, Keratin, type II cytoskeletal 5, CK-5, Keratin-5, K5, 58 kDa cytokeratin, KRT5, CK 5, DDD, EBS 2, EBS2, K5, Keratin 5 (epidermolysis bullosa simplex Dowling-Meara/Kobner/Weber-Cockayne types), Keratin 5, Keratin Type II Cytoskeletal 5, Keratin5, KRT 5, KRT 5A, KRT5.
Verfügbar in folgenden Ländern:worldwide

Keratins are cytoplasmic intermediate filament proteins expressed by epithelial cells. Cytokeratin 5 is a type II keratin. This antibody detects metastatic carcinoma in the pleura, epithelial mesothelioma, almost all squamous cell carcinomas, half of transitional carcinomas, many undifferentiated large cell carcinomas and undiffferentiated large cell carcinomas. A cocktail of CK5, its corresponding partner CK14 and p63 is useful to detect the basal-like phenotype of breast carcinoma and to differentiate normal and prostate cancer.